(21) indicated a summary risk ratio (RR) of 0.78 (95% CI 0.67-0.92) for hormone receptor-positive breast cancer and 1.06 (95% CI 0.70-1.60) for hormone receptor-negative breast cancer in premenopausal women associated with obesity. This evidence concerns the gene NR4A1 and obesity disorder.